In the context of the recent paper The neurobiology of psychedelic drugs: implications for the treatment of mood disorders scientific journal Nature has approached four well-known neuroscience bloggers to each blog about a different aspect of the medical applications of psychedelic drugs.
Neuroskeptic describes how LSD, Psilocybin and Mescaline affect the serotonergic system and considers a psychedelic treatment for depression.
The Neurocritic wonders whether Ketamine might be able to treat this same disorder.
Vaughan Bell over at Mind Hacks covers the therapeutic potential of DMT.
Moheb Costandi from Neurophilosophy investigates the “secret history of psychedelic psychiatry.” On top of that he wrote an overview discussing all four posts for British newspaper The Guardian.